Leaf Systems Bioscience Research Facility, Norfolk

closed

Leaf Systems International has opened a bioscience research and development (R&D) facility at the Norwich Research Park in Norfolk, UK. Bioscience research facility Norfolk, UK June 2016 January 2017 LSI Architects, R G Carter Norwich Research Partners, John Innes Centre (JIC), PBL, Biotechnology and Biological Sciences Research Council (BBSRC) Leaf Systems International has opened a bioscience research and development (R&D) facility at the Norwich Research Park in Norfolk, UK. A spin-off from the John Innes Centre (JIC), Leaf Systems will use the facility to produce proteins, metabolites and complex natural products. The company is a joint venture between JIC, Plant Bioscience (PBL), Norwich Research Partners and the Biotechnology and Biological Sciences Research Council (BBSRC). The joint venture partners collaborated for the development of the R&D facility. Norwich Research Partners was responsible for the facility’s construction. The company submitted the planning application for the project to the South Norfolk Council in February 2016. A ground-breaking ceremony for the facility was held in June 2016 and construction was completed by January 2017. The facility is expected to be fully operational by the end of March 2017. The facility is located at zone two of the Norwich Research Park Enterprise Zone, next to JIC’s laboratory. The Norwich Research Park is situated in 230ha of parkland, which includes 52ha of Enterprise Zone with development land ideal for companies to set up bespoke office space and research facilities. The research park provides flexible laboratory and office accommodation, as well as facilities for growing businesses. The two-storey bioscience R&D facility has a 1,000m² total floor space and includes plant-growing areas and development laboratories. It will serve companies and research organisations by manufacturing adequate quantities of valuable proteins and other natural products to facilitate research and product development. Leaf Systems will work with companies as a contract development partner to build up and increase the production of products or intermediates. It will also work with academic scientists to convert the science into scalable processes or discover new technologies. The company also plans to participate in translational R&D consortia, including European Union (EU) framework programmes. Leaf Systems uses a system called Hypertrans® expression technology to produce proteins in plants. The patented technology was developed at the JIC by Professor George Lomonossoff and Dr Frank Sainsbury as a plant-based system for producing proteins. Proteins developed using Hypertrans can be extracted by crushing the leaves and then purifying the product from the leaves. The technology achieves quick protein production compared to existing commercial processes, which use yeast cultures, bacteria and animal tissue for developing proteins and vaccines. The technology also allows protein to be produced in large quantities in response to emergencies such as epidemics. The technology can also be used for manufacturing products such as pharmaceuticals and vaccines as part of the contract for international R&D partners. It can further be used in the production of antigens, including virus-like particles for vaccine development or nanotechnology. Leaf Systems has licensed the technology to Canadian biopharmaceutical company Medicago, which is using it to produce influenza vaccines for clinical trials in Canada and the US. UK-based architecture firm LSI Architects as responsible for designing the facility, while construction company R G Carter was awarded the construction contract. Get industry leading news, data and analysis delivered to your inbox Give your business an edge with our leading industry insights.

High